Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial.

MLA

Delforge, Michel, et al. “Health-Related Quality of Life in Elderly, Newly Diagnosed Multiple Myeloma Patients Treated with VMP vs. MP: Results from the VISTA Trial.” European Journal of Haematology, vol. 89, no. 1, July 2012, pp. 16–27. EBSCOhost, https://doi.org/10.1111/j.1600-0609.2012.01788.x.

APA

Delforge, M., Dhawan, R., Robinson, D., Meunier, J., Regnault, A., Esseltine, D.-L., Cakana, A., Velde, H., Richardson, P. G., & San Miguel, J. F. (2012). Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial. European Journal of Haematology, 89(1), 16–27. https://doi.org/10.1111/j.1600-0609.2012.01788.x

Chicago

Delforge, Michel, Ravinder Dhawan, Don Robinson, Juliette Meunier, Antoine Regnault, Dixie-Lee Esseltine, Andrew Cakana, Helgi Velde, Paul G. Richardson, and Jesús F. San Miguel. 2012. “Health-Related Quality of Life in Elderly, Newly Diagnosed Multiple Myeloma Patients Treated with VMP vs. MP: Results from the VISTA Trial.” European Journal of Haematology 89 (1): 16–27. doi:10.1111/j.1600-0609.2012.01788.x.